InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,099.13
(
-2.06%
)
Post# of 252503
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

stockbettor

Send PM Follow Ignore
Followers 3
Posts 278
Boards Moderated 0
Alias Born 03/08/2008

stockbettor

Re: ghmm post# 216480

Tuesday, 01/09/2018 3:21:37 PM

Tuesday, January 09, 2018 3:21:37 PM

Post# of 252503
I would add Lilly to the mix, given its 358 immunology partnership with NKTR. Lily's CEO, Dave Ricks, said at JPM yesterday that he wants to build out the company's pipeline, particularly in cancer treatment, adding that that there are attractive companies developing treatments in immunology, diabetes and oncology.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up